Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000205703 | SCV000261786 | benign | Alstrom syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697277 | SCV000532408 | likely benign | not provided | 2020-09-17 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000429728 | SCV001448425 | likely benign | not specified | 2020-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002433912 | SCV002741600 | likely benign | Cardiovascular phenotype | 2019-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001697277 | SCV004700840 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BP7 |
Genetic Services Laboratory, |
RCV000429728 | SCV003839582 | likely benign | not specified | 2022-11-06 | no assertion criteria provided | clinical testing |